Campbell, Kathleen C. M.
Le Prell, Colleen G.
Article History
First Online: 6 February 2018
Compliance with Ethical Standards
:
: Kathleen Campbell is a Distinguished Scholar and Professor at Southern Illinois University School of Medicine, Springfield, IL, USA. In that capacity, she has had grants from multiple funding sources, including the National Institutes of Health and the US Department of Defense, for her research on ototoxicity and noise-induced hearing loss. In addition, she serves as a grant reviewer for those agencies. She also has served as, and continues to serve as, an ototoxicity/audiology consultant for various Pharmaceutical Companies. She is a shareholder in AudiaCare and is the inventor on patents for D-methionine as an otoprotective agent. She receives royalties for her textbookPharmacology and Ototoxicity for Audiologists, and occasionally receives honoraria for her lectures at professional associations. Colleen Le Prell is the Emily and Phil Schepps Distinguished Professor of Hearing Science at the University of Texas, Dallas, TX, USA, where she also serves as Head of the AuD program. She has had grants from multiple funding sources, including the National Institutes of Health and the US Department of Defense, for her research on noise-induced hearing loss. She has served as an ad hoc grant reviewer for those agencies, and is currently serving on the Safety and Occupational Health study section for the National Institute of Occupational Safety and Health. She has also supervised industry contracts, supported by pharmaceutical companies, including Sound Pharmaceuticals, Edison Pharmaceuticals, and Hearing Health Science, and is an inventor on patents owned by the University of Michigan and University of Florida. She receives royalties for her bookNoise-Induced Hearing Loss: Scientific Advancesand occasionally receives honoraria for her lectures at professional associations. Both authors have no other potential conflicts of interest that are directly relevant to the content of this article.